Skip to main content

Namseok Sim

Yonsei University · 医学

研究室紹介

Professor Namseok Sim's research lab specializes in the genetic and molecular mechanisms underlying focal cortical malformations and drug-resistant epilepsy, with a focus on brain somatic mosaicism and its role in epileptogenesis. The lab integrates neurogenomics, digital pathology, and organoid technology to uncover disease-causing mutations, particularly in genes like *SLC35A2* and mTOR pathway components, and to develop non-invasive detection methods using cerebrospinal fluid-derived cell-free DNA. A key direction involves translating histopathological classifications into molecular diagnostics to improve surgical outcomes in pediatric epilepsy. The lab also pioneers long-term human and murine salivary gland organoid models to study epithelial cell biology and regeneration.

somatic mosaicismfocal epilepsyneurogenomicsorganoidsmTOR pathway

Research Overview

Papers
138
Total Citations
1,037
Papers (5y)
121
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
121total
2022
2023
2024
2025
2026
Citations per year (5y)
290total
20222023202420252026

Selected Papers

15
1
Article|141 citations·2019
Precise detection of low-level somatic mutation in resected epilepsy brain tissue
Nam Suk Sim, Ara Ko, Woo Kyeong Kim, Se Hoon Kim, Ju Seong Kim, Kyu‐Won Shim, Eleonora Aronica, Caroline Mijnsbergen, Wim G.M. Spliet, Hyun Yong Koh, Heung Dong Kim, Joon Soo Lee
SJR Q1Acta NeuropathologicaOA
GeneticsBiochemistry, Genetics and Molecular Biology
2
Article|130 citations·2021
Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)
Thomas Bonduelle, Till Hartlieb, Sara Baldassari, Nam Suk Sim, Se Hoon Kim, Hoon‐Chul Kang, Katja Kobow, Roland Coras, Mathilde Chipaux, Georg Dorfmüller, Homa Adle‐Biassette, Eleonora Aronica
SJR Q1Acta Neuropathologica CommunicationsOA

Focal malformations of cortical development (MCD) are linked to somatic brain mutations occurring during neurodevelopment. Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized clinico-pathological entity associated with pediatric drug-resistant focal epilepsy, and amenable to neurosurgical treatment. MOGHE is histopathologically characterized by clusters of increased oligodendroglial cell densities, patchy zones of hypomyelination,

Psychiatry and Mental healthMedicine
3
Article|100 citations·2021
Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial
Ingmar Blümcke, Roland Coras, Robyn M. Busch, Marcia Morita‐Sherman, Dennis Lal, Richard A. Prayson, Fernando Cendes, Íscia Lopes‐Cendes, Fábio Rogério, Vanessa Simão de Almeida, Cristiane S. Rocha, Nam Suk Sim
SJR Q1EpilepsiaOA

OBJECTIVE: Focal cortical dysplasia (FCD) is a major cause of difficult-to-treat epilepsy in children and young adults, and the diagnosis is currently based on microscopic review of surgical brain tissue using the International League Against Epilepsy classification scheme of 2011. We developed an iterative histopathological agreement trial with genetic testing to identify areas of diagnostic challenges in this widely used classification scheme. METHODS: Four web-based digital pathology trials w

Psychiatry and Mental healthMedicine
4
Article|96 citations·2022
Salivary gland organoid culture maintains distinct glandular properties of murine and human major salivary glands
Yeo‐Jun Yoon, Donghyun Kim, Kwon Yong Tak, Seungyeon Hwang, Ji‐Sun Kim, Nam Suk Sim, Jae-Min Cho, Dojin Choi, Youngmi Ji, Junho K. Hur, Hyunki Kim, Jong-Eun Park
SJR Q1Nature CommunicationsOA

Salivary glands that produce and secrete saliva, which is essential for lubrication, digestion, immunity, and oral homeostasis, consist of diverse cells. The long-term maintenance of diverse salivary gland cells in organoids remains problematic. Here, we establish long-term murine and human salivary gland organoid cultures. Murine and human salivary gland organoids express gland-specific genes and proteins of acinar, myoepithelial, and duct cells, and exhibit gland functions when stimulated with

PhysiologyMedicine
5
Article|79 citations·2018
Brain somatic mutations in SLC35A2 cause intractable epilepsy with aberrant N-glycosylation
Nam Suk Sim, Youngsuk Seo, Jae Seok Lim, Woo Kyeong Kim, Hyeonju Son, Heung Dong Kim, Sangwoo Kim, Hyun Joo An, Hoon‐Chul Kang, Se Hoon Kim, Dong-Seok Kim, Jeong Ho Lee
SJR Q1Neurology GeneticsOA

Our study suggests that brain somatic mutations in <i>SLC35A2</i> cause intractable focal epilepsy with NLFE or mMCD via aberrant N-glycosylation in the affected brain.

GeneticsBiochemistry, Genetics and Molecular Biology
6
Article|56 citations·2021
Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients
Seyeon Kim, Sara Baldassari, Nam Suk Sim, Mathilde Chipaux, Georg Dorfmüller, Dong Seok Kim, Won Seok Chang, Valérie Taly, Jeong Ho Lee, Stéphanie Baulac
SJR Q1Annals of NeurologyOA

Brain mosaic mutations are a major cause of refractory focal epilepsies with cortical malformations such as focal cortical dysplasia, hemimegalencephaly, malformation of cortical development with oligodendroglial hyperplasia in epilepsy, and ganglioglioma. Here, we collected cerebrospinal fluid (CSF) during epilepsy surgery to search for somatic variants in cell-free DNA (cfDNA) using targeted droplet digital polymerase chain reaction. In 3 of 12 epileptic patients with known somatic mutations p

Cancer ResearchBiochemistry, Genetics and Molecular Biology
7
Article|41 citations·2021
Balloon cells promote immune system activation in focal cortical dysplasia type 2b
Till S. Zimmer, Diede W. M. Broekaart, Mark J. Luinenburg, Caroline Mijnsbergen, Jasper J. Anink, Nam Suk Sim, Iliana Michailidou, Floor E. Jansen, Peter C. van Rijen, Jeong Ho Lee, Liesbeth François, Jonathan van Eyll
SJR Q1Neuropathology and Applied NeurobiologyOA

AIMS: Focal cortical dysplasia (FCD) type 2 is an epileptogenic malformation of the neocortex associated with somatic mutations in the mammalian target of rapamycin (mTOR) pathway. Histopathologically, FCD 2 is subdivided into FCD 2a and FCD 2b, the only discriminator being the presence of balloon cells (BCs) in FCD 2b. While pro-epileptogenic immune system activation and inflammatory responses are commonly detected in both subtypes, it is unknown what contextual role BCs play. METHODS: The pres

Psychiatry and Mental healthMedicine
8
Article|38 citations·2019
Global Analysis of Intercellular Homeodomain Protein Transfer
Eun Jung Lee, Namsuk Kim, Jun Woo Park, Kyung Hwa Kang, Woo-Il Kim, Nam Suk Sim, Chan-Seok Jeong, Seth Blackshaw, Marc Vidal, Sung‐Oh Huh, Dongsup Kim, Jeong Ho Lee
SJR Q1Cell ReportsOA

The homeodomain is found in hundreds of transcription factors that play roles in fate determination via cell-autonomous regulation of gene expression. However, some homeodomain-containing proteins (HPs) are thought to be secreted and penetrate neighboring cells to affect the recipient cell fate. To determine whether this is a general characteristic of HPs, we carried out a large-scale validation for intercellular transfer of HPs. Our screening reveals that intercellular transfer is a general fea

Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|29 citations·2022
Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum‐Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Jee Hung Kim, Yoon Woo Koh, Inkyung Jung
SJR Q1Clinical Cancer ResearchOA

PURPOSE: Monotherapy with eribulin or gemcitabine has been found to be moderately effective in treating soft-tissue sarcomas (STS). In this study, we evaluated the efficacy and safety of eribulin-gemcitabine combination therapy for the two most common histologic types of STS, liposarcoma and leiomyosarcoma. PATIENTS AND METHODS: In this nonrandomized, multicenter, phase II study, we included patients with progressive disease who had received one or two courses of chemotherapy that included doxor

Pulmonary and Respiratory MedicineMedicine
10
Article|28 citations·2020
Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations
Hyun Jin Park, Chang Ho Shin, Won Joon Yoo, Tae‐Joon Cho, Man Jin Kim, Moon‐Woo Seong, Sung Sup Park, Jeong Ho Lee, Nam Suk Sim, Jung Min Ko
SJR Q1Orphanet Journal of Rare DiseasesOA

BACKGROUND: Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) belongs to a group of conditions called the PIK3CA-related overgrowth spectrum (PROS). The varying phenotypes and low frequencies of each somatic mosaic variant make confirmative diagnosis difficult. We present 12 patients who were diagnosed clinically and genetically with MCAP. Genomic DNA was extracted mainly from the skin of affected lesions, also from peripheral blood leukocytes and buccal epithelial cells, and

SurgeryMedicine
11
Article|28 citations·2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Chang Gon Kim, Min Hee Hong, Dahee Kim, Brian Hyohyoung Lee, Hyunwook Kim, Chan‐Young Ock, Geoffrey Kelly, Yoon Ji Bang, Gamin Kim, Jung Eun Lee, Chaeyeon Kim, Se‐Heon Kim
SJR Q1Clinical Cancer Research

PURPOSE: Clinical implications of neoadjuvant immunotherapy in patients with locally advanced but resectable head and neck squamous cell carcinoma (HNSCC) remain largely unexplored. PATIENTS AND METHODS: Patients with resectable HNSCC were randomized to receive a single dose of preoperative durvalumab (D) with or without tremelimumab (T) before resection, followed by postoperative (chemo)radiotherapy based on multidisciplinary discretion and 1-year D treatment. Artificial intelligence (AI)-power

OncologyMedicine
12
Article|27 citations·2024
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes
Junha Cha, Dahee Kim, Gamin Kim, Jae-Won Cho, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Chang Gon Kim, Nam Suk Sim, Hyun Jun Hong, Jung Eun Lee, Martin Hemberg
SJR Q1Journal for ImmunoTherapy of CancerOA

Background Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV-positive) is associated with better clinical outcomes than HPV-negative OPSCC. However, the clinical benefits of immunotherapy in patients with HPV-positive OPSCC remain unclear. Methods To identify the cellular and molecular factors that limited the benefits associated with HPV in OPSCC immunotherapy, we performed single-cell RNA (n=20) and T-cell receptor sequencing (n=10) analyses of tonsil or base o

Molecular BiologyBiochemistry, Genetics and Molecular Biology
13
Article|25 citations·2015
Endoscopic retroauricular thyroidectomy: preliminary results
Hyung Kwon Byeon, F. Christopher Holsinger, Ralph P. Tufano, Jae Hong Park, Nam Suk Sim, Won Shik Kim, Eun Chang Choi, Yoon Woo Koh
SJR Q1Surgical EndoscopyOA
SurgeryMedicine
14
Article|24 citations·2014
Long-term effects of repetitive transcranial magnetic stimulation in unilateral tinnitus
Han Jo Kim, Deog Young Kim, Hyo I. Kim, Hee So Oh, Nam Suk Sim, In Seok Moon
SJR Q1The LaryngoscopeOA

Daily application of 1-Hz rTMS to the temporoparietal area is safe and has long-term beneficial effects. The laterality of stimulation is not the decisive factor.

NeurologyNeuroscience
15
Article|22 citations·2013
Enlarged Cochlear Aqueducts
Bo Gyung Kim, Nam Suk Sim, Sung Huhn Kim, Un‐Kyung Kim, Soyeun Kim, Jae Young Choi
SJR Q1Otology & NeurotologyOA

The CA is a potential pathway for CSF gushers between the subarachnoid space and the inner ear. Therefore, we suggest that evaluation of the CA by TBCT may be helpful in predicting intraoperative CSF gushers in patients with EVA.

Sensory SystemsNeuroscience

Research Areas

OncologyOtorhinolaryngologyPulmonary and Respiratory MedicineSurgeryCancer ResearchPhysiology

Namseok Simの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。